Commentary · 27 May 2026
Conference abstractPublished 12 Oct 2017
SILVER-BASED ANTIBACTERIAL TREATMENTS ON BIOMEDICAL DEVICES FOR DIABETIC PATIENTS
University of Salento, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Silver nanoparticles (AgNPs) have attracted research interests in preventing wound-related infections and recently have been widely used in diabetic foot disease related biomedical devices. In this study, we optimized a specific AgNPs deposition process on natural textiles for the prevention of the infections in diabetic foot. Nano-silver has long been recognized as one of the most effective natural antimicrobial agents, and through ad-hoc optimized photo-activated reaction AgNPs were successfully synthesized in-situ on the fibers of the substrate. Silver nitrate was used as silver precursor, and a hydro-alcoholic solution was used as reducing agent. Three different silver concentrations (0.25% 0.5% and 1 % of Silver Nitrate), two kind of impregnation (dip coating and spray coating) and two different reaction times (10 and 20 minutes) were used as variable of the process. 100% cotton was used as textile substrate, and all the silver-treated samples obtained were tested against different microorganisms including Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), to optimized the specific treatment in terms of antibacterial activity. The results of the agar diffusion test performed on the treated substrates, are shown in the Figure 1. The results showed distinct inhibition zones to proliferation of all the microorganisms tested in the dip coated sample, while no inhibition zones was observed in the spray coated substrates. The inhibition zone was higher than the minimum (1mm) required to be considered a good antibacterial material, according to the standard used (SNV 195920-1992). Acknowledgment: The authors thank the support from Department of Engineering for Innovation (DII) of the University of Salento and Cluster DIABESITY CARE âÂ?Â? CUP B38I15000450008 (Avviso Aiuti a Sostegno dei Cluster Tecnologici Regionali per lâÂ?Â?Innovazione) which funded this study.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pancreatic Disorders & Therapy.
Short communication · 27 May 2026
Immunometabolic Interactions in Pancreatic Disease: Crosstalk Between Energy Dysregulation, Immune Activation, and Tissue Dysfunction
Commentary · 27 May 2026
Microvascular Dysfunction in Pancreatic Disorders: Endothelial Injury, Perfusion Failure, and Tissue Consequences
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPancreatic Disorders & Therapy
- SubjectGastroenterology & Hepatology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Riccardo Raho”
- BylineArticles whose byline prints “Federica Paladini”
- BylineArticles whose byline prints “Mauro Pollini”
- BylineArticles whose byline prints “Alessandro Sannino”
